key: cord-0856178-wb493vj4
authors: Bansal, Priya; Bingemann, Theresa A.; Greenhawt, Matthew; Mosnaim, Giselle; Nanda, Anil; Oppenheimer, John; Sharma, Hemant; Stukus, David; Shaker, Marcus
title: Reply to Challenges to paediatric services during COVID-19 Pandemic: a London, UK perspective
date: 2020-06-24
journal: J Allergy Clin Immunol Pract
DOI: 10.1016/j.jaip.2020.06.026
sha: 36dfa5d0e2b28948d977c6bc1a50b2ce4ed60eec
doc_id: 856178
cord_uid: wb493vj4

nan

Matthew Greenhawt: Matthew Greenhawt is supported by grant #5K08HS024599-02 from the Agency for Healthcare Research and Quality; is an expert panel and coordinating committee member of the NIAID-sponsored Guidelines for Peanut Allergy Prevention; has served as a consultant for the Canadian Transportation Agency, Thermo Fisher, Intrommune, and Aimmune Therapeutics; is a member of physician/medical advisory boards for Aimmune Therapeutics, DBV Technologies, Sanofi/Genzyme, Genentech, Glaxo Smith Kline, Merck, Nutricia, Kaleo Pharmaceutical, Nestle, Acquestive, Allergy Therapeutics, Allergenis, Aravax, and Monsanto; is a member of the scientific advisory council for the National Peanut Board; has received honorarium for lectures from Thermo Fisher, Aimmune Therapeutics, DBV Technologies, Before Brands, multiple state allergy societies, the American College of Allergy Asthma and Immunology, the European Academy of Allergy and Clinical Immunology; is an associate editor for the Annals of Allergy, Asthma, and Immunology; and is a member of the Joint Taskforce on Allergy Practice Parameters Giselle Mosnaim: received research grant support from Astra Zeneca and GlaxoSmithKline and currently receives research grant support from Propeller Health; owned stock in Electrocore; and served as a consultant and/or member of a scientific advisory board for GlaxoSmithKline, Sanofi-Regeneron, Teva, Novartis, Astra Zeneca, Boehringer Ingelheim and Propeller Health. Marcus Shaker: has a brother who is CEO of Altrix Medical, is a member of the Joint Task force on Practice Parameters, and serves on the editorial boards of the Journal of Allergy and Clinical Immunology In Practice, Annals of Allergy, Asthma, and Immunology, and the Journal of Food Allergy.

Gritz et al 1 make several significant points regarding wellness during the COVID-19 pandemic in pediatrics in London, U.K. We appreciate their contribution to recognizing the critical nature of wellness, and the important issues at hand. The pandemic has caused unprecedented transformations of healthcare facilities worldwide, including training programs. 1, 2 A shift to telemedicine and virtual teaching has occurred as part of the initial phase of the pandemic response. However, as the gradual reopening of organizations, including healthcare facilities, transpires, we face new challenges of how to deliver the safest and most effective care.

A number of considerations exist for resuming in office practice, including physician and staff safety, logistics of the practice space, and resumption of procedures in the office. 3, 4 Alongside of this, physicians in training and new fellowship graduates have their own additional stressors, including future employment and economic uncertainties. Prior to the pandemic, physician wellness was an escalating issue; unquestionably, in the aftermath of the first wave of the pandemic, there is a paramount need to continue to assess and address physician wellness needs. 2 To accomplish this, we as a medical community need to collaborate, learn from the supports we are utilizing during this crisis, and take deliberate action to create an enduring culture of wellness as we navigate both daily practice and potential future waves of the pandemic. Priya Bansal, MD, Asthma and Allergy Wellness Center, St. Charles, IL

Challenges to paediatric services during COVID-19 Pandemic: a London, UK perspective

Clinician wellness during the COVID-19 pandemic: Extraordinary times and unusual challenges for the allergist/immunologist

Suggestions or considerations for resuming practices. Resources for allergy and immunology clinicians during the covid-19 pandemic. www.aaaai.org

A phased approach to resuming suspended allergy/immunology clinical services